Pharmaceutical major Dr Reddy's
Laboratories shined on Tuesday after it reported a
better-than-expected rise of 32.37% in consolidated net profit to
Rs 4.07 billion for the quarter ended Sept 30, 2012 as compared to
Rs 3.08 billion in the same period last year.
Analysts on an average were expecting profit to come at Rs 3.65 billion.
Shares ofthe companyare trading at Rs 1,722, up Rs 25.85, or
1.52% at the Bombay Stock Exchange (BSE) on Tuesday at 2:13 p.m. 
Total consolidated income has increased
by 27.03% to Rs 28.81 billion for the quarter ended Sept 30, 2012
from Rs 22.68 billion in the year ago period.The scrip has touched
an intra-day high of Rs 1,739.00 and low of Rs 1,701.55. The total
volume of shares traded at the BSE is 81,518.In the earlier
session, the shares climbed 1.62%, or Rs 27, at Rs 1,696.15.
Currently, the stock is trading down 5.28% from its 52-week high of
Rs 1,818 and above 14.72% over the 52-week low of Rs
1,501.
Post a Comment